These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28954920)

  • 1. Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Shams T; Auchus AP; Oparil S; Wright CB; Wright J; Furlan AJ; Sila CA; Davis BR; Pressel S; Yamal JM; Einhorn PT; Lerner AJ;
    Stroke; 2017 Nov; 48(11):3078-3085. PubMed ID: 28954920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT.
    Shahu A; Herrin J; Dhruva SS; Desai NR; Davis BR; Krumholz HM; Spatz ES
    J Am Heart Assoc; 2019 Aug; 8(15):e012277. PubMed ID: 31362591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
    Yamal JM; Oparil S; Davis BR; Alderman MH; Calhoun DA; Cushman WC; Fendley HF; Franklin SS; Habib GB; Pressel SL; Probstfield JL; Sastrasinh S;
    J Am Soc Hypertens; 2014 Nov; 8(11):808-19. PubMed ID: 25455006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
    Piller LB; Baraniuk S; Simpson LM; Cushman WC; Massie BM; Einhorn PT; Oparil S; Ford CE; Graumlich JF; Dart RA; Parish DC; Retta TM; Cuyjet AB; Jafri SZ; Furberg CD; Saklayen MG; Thadani U; Probstfield JL; Davis BR;
    Circulation; 2011 Oct; 124(17):1811-8. PubMed ID: 21969009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study.
    Bikkina M; Levy D; Evans JC; Larson MG; Benjamin EJ; Wolf PA; Castelli WP
    JAMA; 1994 Jul; 272(1):33-6. PubMed ID: 8007076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
    Hypertension; 2003 Sep; 42(3):239-46. PubMed ID: 12925554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial.
    Hornslien AG; Sandset EC; Bath PM; Wyller TB; Berge E;
    Stroke; 2013 Jul; 44(7):2022-4. PubMed ID: 23660849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease.
    Dewland TA; Soliman EZ; Davis BR; Magnani JW; Yamal JM; Piller LB; Haywood LJ; Alonso A; Albert CM; Marcus GM;
    JAMA Intern Med; 2016 Aug; 176(8):1085-92. PubMed ID: 27367818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study.
    Muntner P; Whittle J; Lynch AI; Colantonio LD; Simpson LM; Einhorn PT; Levitan EB; Whelton PK; Cushman WC; Louis GT; Davis BR; Oparil S
    Ann Intern Med; 2015 Sep; 163(5):329-38. PubMed ID: 26215765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Dhruva SS; Huang C; Spatz ES; Coppi AC; Warner F; Li SX; Lin H; Xu X; Furberg CD; Davis BR; Pressel SL; Coifman RR; Krumholz HM
    Hypertension; 2017 Jul; 70(1):94-102. PubMed ID: 28559399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life after lacunar stroke: the Secondary Prevention of Small Subcortical Strokes study.
    Dhamoon MS; McClure LA; White CL; Lau H; Benavente O; Elkind MS
    J Stroke Cerebrovasc Dis; 2014; 23(5):1131-7. PubMed ID: 24177006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients.
    Qin X; Li J; Spence JD; Zhang Y; Li Y; Wang X; Wang B; Sun N; Chen F; Guo J; Yin D; Sun L; Tang G; He M; Fu J; Cai Y; Shi X; Ye P; Chen H; Zhao S; Chen M; Gao C; Kong X; Hou FF; Huang Y; Huo Y
    Stroke; 2016 Nov; 47(11):2805-2812. PubMed ID: 27729579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent and Joint Effect of Brachial-Ankle Pulse Wave Velocity and Blood Pressure Control on Incident Stroke in Hypertensive Adults.
    Song Y; Xu B; Xu R; Tung R; Frank E; Tromble W; Fu T; Zhang W; Yu T; Zhang C; Fan F; Zhang Y; Li J; Bao H; Cheng X; Qin X; Tang G; Chen Y; Yang T; Sun N; Li X; Zhao L; Hou FF; Ge J; Dong Q; Wang B; Xu X; Huo Y
    Hypertension; 2016 Jul; 68(1):46-53. PubMed ID: 27217412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
    Guekht A; Skoog I; Edmundson S; Zakharov V; Korczyn AD
    Stroke; 2017 May; 48(5):1262-1270. PubMed ID: 28432265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients.
    Okin PM; Kjeldsen SE; Devereux RB
    Stroke; 2015 Aug; 46(8):2113-8. PubMed ID: 26089332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.